Ameritas Advisory Services’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13
Closed -$293 2623
2025
Q2
$293 Buy
+13
New +$320 ﹤0.01% 2735

Other funds holding MRNY

Ameritas Advisory Services's MRNY Position: Q3 2025 in Review

Ameritas Advisory Services sold out of YieldMax MRNA Option Income Strategy ETF (MRNY) in Q3 2025, closing a stake of 13 shares — an estimated $293 sold.

Ameritas Advisory Services first reported a position in MRNY in Q2 2025 and held it in 1 quarter. The position peaked at $293 in Q2 2025. 13 funds tracked by Wall St. Rank hold MRNY as of Q3 2025.

  • Ameritas Advisory Services reported no remaining YieldMax MRNA Option Income Strategy ETF position as of Q3 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 13 YieldMax MRNA Option Income Strategy ETF shares in Q3 2025, an estimated $293.
  • Ameritas Advisory Services first reported a position in YieldMax MRNA Option Income Strategy ETF in Q2 2025 and held it in 1 quarter.
  • Ameritas Advisory Services's YieldMax MRNA Option Income Strategy ETF position peaked at $293 in Q2 2025.
  • 13 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q3 2025.

Based on Ameritas Advisory Services's 13F filing for Q3 2025, filed 6 Nov 2025.